Accelerated approval regulations may need overhaul, panel suggests

J Natl Cancer Inst. 2005 Dec 21;97(24):1802-4. doi: 10.1093/jnci/dji456.
No abstract available

Publication types

  • News

MeSH terms

  • Antibiotics, Antineoplastic / therapeutic use
  • Antineoplastic Agents / therapeutic use*
  • Clinical Trials as Topic / standards
  • Doxorubicin / therapeutic use
  • Drug Approval / organization & administration*
  • Drugs, Investigational / therapeutic use*
  • Humans
  • United States
  • United States Food and Drug Administration

Substances

  • Antibiotics, Antineoplastic
  • Antineoplastic Agents
  • Drugs, Investigational
  • Doxorubicin